Not Tagged
bms,janssen
['janssen', 'bristol']
 whereas competitor janssen is now at the fda with a gprc5d-directed bispecific, bristol myers squibb touts early data on the "one and done" potential of car-t 
covering the science, people, $ & biotechs behind new drugs @Endpts | klahucik@endpointsnews.com | askin Qs, joggin 26.2 | ?? ?? ?? | XC coach | he/him ??????